C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/20 (2006.01) A61K 38/17 (2006.01) A61K 38/21 (2006.01) A61K 38/22 (2006.01) A61K 48/00 (2006.01) A61P 7/06 (2006.01) C12N 15/18 (2006.01) C12N 15/67 (2006.01) C12N 15/85 (2006.01)
Patent
CA 2664318
The present invention is directed to long-lasting therapeutic formulations and their methods of use wherein the formulation comprises a genetically modified micro-organ that comprises a vector which comprises a nucleic acid sequence operably linked to one or more regulatory sequences, wherein the nucleic acid sequence encodes a therapeutic polypeptide, such as erythropoietin or interferon alpha.
La présente invention concerne des formulations thérapeutiques de longue durée et leurs procédés d'utilisation, la formulation comprenant un micro-organe génétiquement modifié qui comprend un vecteur qui comprend une séquence d'acide nucléique liée de façon fonctionnelle à une ou plusieurs séquences régulatrices, la séquence d'acide nucléique codant pour un polypeptide thérapeutique, tel que l'érythropoïétine ou un interféron alpha.
Medgenics Medical Israel Ltd.
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
LandOfFree
Long lasting drug formulations does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Long lasting drug formulations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Long lasting drug formulations will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1903204